Fisher & Paykel Healthcare's (ASX:FPH, NZE:FPH) result was in line with Jefferies' forecasts for revenue, and 2% above net profit after tax, with a higher-than-expected earnings before interest and tax margin, Jefferies said in a Tuesday note.
Fisher & Paykel reported fiscal year 2026 underlying earnings of NZ$0.793 per share, up from NZ$0.639 a year earlier. Operating revenue for the 12 months ended March 31 was NZ$2.31 billion, compared with NZ$2.02 billion a year earlier.
Jefferies forecasted net profit of NZ$459 million and sales revenue of NZ$2.3 billion. The firm reported higher-than-expected revenue in the hospital segment and lower-than-expected revenue in homecare.
The investment firm retained its buy rating on Fisher & Paykel Healthcare and its price targets of AU$33.50 per share and NZ$41 per share.